The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation

CD1d-restricted lymphocytes recognize a broad lipid range. However, how CD1d-restricted lymphocytes translate T cell receptor (TCR) recognition of lipids with similar group heads into distinct biological responses remains unclear. Using a soluble invariant NKT (iNKT) TCR and a newly engineered antibody specific for α-galactosylceramide (α-GalCer)–human CD1d (hCD1d) complexes, we measured the affinity of binding of iNKT TCR to hCD1d molecules loaded with a panel of α-GalCer analogues and assessed the rate of dissociation of α-GalCer and α-GalCer analogues from hCD1d molecules. We extended this analysis by studying iNKT cell synapse formation and iNKT cell activation by the same panel of α-GalCer analogues. Our results indicate the unique role of the lipid chain occupying the hCD1d F′ channel in modulating TCR binding affinity to hCD1d–lipid complexes, the formation of stable immunological synapse, and cell activation. These data are consistent with previously described conformational changes between empty and loaded hCD1d molecules (Koch, M., V.S. Stronge, D. Shepherd, S.D. Gadola, B. Mathew, G. Ritter, A.R. Fersht, G.S. Besra, R.R. Schmidt, E.Y. Jones, and V. Cerundolo. 2005. Nat. Immunol 6:819–826), suggesting that incomplete occupation of the hCD1d F′ channel results in conformational differences at the TCR recognition surface. This indirect effect provides a general mechanism by which lipid-specific lymphocytes are capable of recognizing both the group head and the length of lipid antigens, ensuring greater specificity of antigen recognition.

[1]  Ian A. Wilson,et al.  Structural Characterization of Mycobacterial Phosphatidylinositol Mannoside Binding to Mouse CD1d12 , 2006, The Journal of Immunology.

[2]  I. Wilson,et al.  Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria , 2006, Nature Immunology.

[3]  T. Zal,et al.  Altered peptide ligands induce delayed CD8-T cell receptor interaction--a role for CD8 in distinguishing antigen quality. , 2006, Immunity.

[4]  R. Brutkiewicz.  CD1d Ligands: The Good, the Bad, and the Ugly1 , 2006, The Journal of Immunology.

[5]  Rajat Varma,et al.  T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. , 2006, Immunity.

[6]  Bent K Jakobsen,et al.  Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors , 2006, The Journal of Immunology.

[7]  Arup K Chakraborty,et al.  Molecular flexibility can influence the stimulatory ability of receptor-ligand interactions at cell-cell junctions. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Natalie A. Borg,et al.  A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition , 2006, The Journal of experimental medicine.

[9]  D. Stuart,et al.  Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors , 2006, The Journal of experimental medicine.

[10]  I. Wilson,et al.  Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Chi-Huey Wong,et al.  Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity , 2005, The Journal of experimental medicine.

[12]  Takashi Saito,et al.  Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76 , 2005, Nature Immunology.

[13]  Rajat Varma,et al.  Actin and agonist MHC–peptide complex–dependent T cell receptor microclusters as scaffolds for signaling , 2005, The Journal of experimental medicine.

[14]  I. Wilson,et al.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor , 2005, Nature Immunology.

[15]  T. Zal,et al.  Nonstimulatory peptides contribute to antigen-induced CD8–T cell receptor interaction at the immunological synapse , 2005, Nature Immunology.

[16]  R. Steinman,et al.  Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients , 2005, The Journal of experimental medicine.

[17]  Andrew Sewell,et al.  Structural and kinetic basis for heightened immunogenicity of T cell vaccines , 2005, The Journal of experimental medicine.

[18]  G. Besra,et al.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Harris,et al.  Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. , 2004, The Journal of clinical investigation.

[20]  Jelena S. Bezbradica,et al.  Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct α- and β-Anomeric Glycolipids1 , 2004, The Journal of Immunology.

[21]  T. Yamamura,et al.  The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. , 2004, The Journal of clinical investigation.

[22]  Michael Loran Dustin,et al.  LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. , 2004, Immunity.

[23]  Michael B Brenner,et al.  CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.

[24]  Mark M Davis,et al.  Linking molecular and cellular events in T-cell activation and synapse formation. , 2003, Seminars in immunology.

[25]  M. Lafleur,et al.  Structural Features of the Acyl Chain Determine Self-phospholipid Antigen Recognition by a CD1d-restricted Invariant NKT (iNKT) Cell* , 2003, Journal of Biological Chemistry.

[26]  A. Harris,et al.  NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells 1 , 2003, The Journal of Immunology.

[27]  Jelena S. Bezbradica,et al.  Another View of T Cell Antigen Recognition: Cooperative Engagement of Glycolipid Antigens by Va14Ja18 Natural TCR 1 , 2003, The Journal of Immunology.

[28]  Meir Glick,et al.  Stable, soluble T-cell receptor molecules for crystallization and therapeutics. , 2003, Protein engineering.

[29]  R. Steinman,et al.  Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein , 2003 .

[30]  Mark M Davis,et al.  Dynamics of p56lck translocation to the T cell immunological synapse following agonist and antagonist stimulation. , 2002, Immunity.

[31]  K. Garcia,et al.  The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex1 , 2002, The Journal of Immunology.

[32]  V. Cerundolo,et al.  Vα24-JαQ-Independent, CD1d-Restricted Recognition of α-Galactosylceramide by Human CD4+ and CD8αβ+ T Lymphocytes1 , 2002, The Journal of Immunology.

[33]  Vasso Apostolopoulos,et al.  Structural Comparison of Allogeneic and Syngeneic T Cell Receptor–Peptide-Major Histocompatibility Complex Complexes , 2002, The Journal of experimental medicine.

[34]  G. Besra,et al.  Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation , 2002, Nature Immunology.

[35]  Andrea Iaboni,et al.  The immunological synapse and CD28-CD80 interactions , 2001, Nature Immunology.

[36]  T. Yamamura,et al.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells , 2001, Nature.

[37]  V. Cerundolo,et al.  Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC1 , 2001, The Journal of Immunology.

[38]  R. Tisch,et al.  Class I Major Histocompatibility Complex Anchor Substitutions Alter the Conformation of T Cell Receptor Contacts* , 2001, The Journal of Biological Chemistry.

[39]  A. Fersht,et al.  Human CD1d–glycolipid tetramers generated by in vitro oxidative refolding chromatography , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Schmidt,et al.  Total synthesis of α-galactosyl cerebroside , 2000 .

[41]  I. Wilson,et al.  Structural requirements for antigen presentation by mouse CD1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  K. Garcia,et al.  A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. , 2000, Immunity.

[43]  J. Slotte,et al.  Analysis of natural and synthetic sphingomyelins using high-performance thin-layer chromatography. , 1999, European journal of biochemistry.

[44]  S. Bromley,et al.  The immunological synapse: a molecular machine controlling T cell activation. , 1999, Science.

[45]  B M Baker,et al.  Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.

[46]  B K Jakobsen,et al.  TCR binding to peptide-MHC stabilizes a flexible recognition interface. , 1999, Immunity.

[47]  M. Kronenberg,et al.  Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. , 1998, Journal of immunology.

[48]  P. A. Peterson,et al.  Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. , 1997, Science.

[49]  D. Stuart,et al.  Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8 , 1996, The Journal of experimental medicine.

[50]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[51]  Robert B. Gennis,et al.  Biomembranes: Molecular Structure and Function , 1988 .

[52]  D I Stuart,et al.  Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. , 1979, Journal of molecular biology.

[53]  Gerd Ritter,et al.  The crystal structure of human CD1d with and without alpha-galactosylceramide. , 2005, Nature immunology.

[54]  Jelena S. Bezbradica,et al.  Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids. , 2004, Journal of immunology.

[55]  Jelena S. Bezbradica,et al.  Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected]. , 2003, Journal of immunology.

[56]  K. Garcia,et al.  The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. , 2002, Journal of immunology.

[57]  V. Cerundolo,et al.  Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. , 2002, Journal of immunology.

[58]  J. Bell,et al.  BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. , 1999, Analytical biochemistry.